Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Cardiovascular Drugs and Therapy|September 1, 2012
Propionyl-L-carnitine improves endothelial function, microcirculation and pain management in critical limb ischemiaS De Marchi, S Zecchetto, A Rigoni, et al.Life Sciences|July 19, 2001
Vascular adhesion molecule-1 and markers of platelet function before and after a treatment with iloprost or a supervised physical exercise program in patients with peripheral arterial diseaseE Arosio, P Minuz, M Prior, et al.Clinical Pharmacology and Therapeutics|January 12, 2017
Cost Evaluation of Irinotecan-Related Toxicities Associated With the UGT1A1*28 Patient GenotypeR Roncato, E Cecchin, M Montico, et al.Frontiers in Pharmacology|May 31, 2023
Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementationA Bignucolo, E De Mattia, R Roncato, et al.Scandinavian Journal of Medicine & Science in Sports|December 21, 2012
Inflammation and atrial remodeling after a mountain marathonM Wilhelm, T Zueger, S De Marchi, et al.Journal of Internal Medicine|May 16, 2000
Hepatitis C virus risk: a hepatitis C virus related syndromeC Mazzaro, G Panarello, F Tesio, et al.International Journal of Immunogenetics|January 12, 2016
Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insightM Garziera, E Catamo, S Crovella, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 19, 2010
MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancerValli De Re, R Cannizzaro, V Canzonieri, et al.The Pharmacogenomics Journal|August 8, 2012
A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimenE Cecchin, M D'Andrea, S Lonardi, et al.ESMO Open|March 29, 2023
Implementation of dihydropyrimidine dehydrogenase deficiency testing in EuropeM de With, A Sadlon, E Cecchin, et al.Pageof 8